Rivastigmine vs placebo
Acceptability · Apathy in people with mild‐to‐moderate Alzheimer's disease
Rivastigmine probably leads to higher acceptability of treatment (as measured by withdrawals from trials… compared with placebo (moderate certainty).
1 finding from 1 review
- OR 2.01 [1.71, 2.37]7 studies · 3569 participantsModerate